|
Interleukin Genetics Reports Fourth Quarter and Year-End Results
Revenue for the quarter was $935,000 compared to $761,000 in the same quarter of ... Factors that could cause actual results to differ materially from those ...
http://www.ilgenetics.com/content/about-interleukin/newsDetail.jsp/q/news-id/44
Public Auction Results
Results 1 - 10 of 265 total. Shinwa Art Auction ... 100,000 - 200,000 YEN (935 - 1,870 US$) Sold For. 200,000 YEN (1,884 US$) Currency Converter ...
http://www.artnet.com/PDB/PublicAuctionResults.aspx?collection_id=142094
935 Summary and Analysis Summary
935,000 Awarded In Maternity Leave Suit. 03/26/1992: 605 words, approx. 2 pages ... More Information. Search Results for "935" New Search. Q & A ...
http://www.bookrags.com/935
Insignia Announces 1996 Third Quarter Results
... in this quarter's results is an expense of $935,000 for aborted acquisition costs. ... includes the one time charge of $935,000 in failed transaction costs. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/45670&EDATE=
Sale Results, Financial Advisory Services, Ehlers & Associates
Ehlers & Associates provides Sale Results and financial advisory services to public sector clients ... 3,935,000* General Obligation Corporate Purpose Bonds ...
http://www.ehlers-inc.com/sale_results.php
www.katahdintrust.com/pr_4_18_07.asp
... quarter results Katahdin Trust Company President and CEO Jon J. Prescott said, ... Our first quarter net income of $935,000 represented a slight increase over the ...
http://www.katahdintrust.com/pr_4_18_07.asp
IOMED Reports Fourth Quarter and Fiscal 2004 Operating Results
... June 30, 2004, sales were $3,163,000, marking the third consecutive ... 11,935,000 a year ago. Gross margin was 62% compared with 63% a year ago. The decrease ...
http://www.iomed.com/pdf/083004%20Q4%202004%20Results.pdf
busco novia
Search Results: 935,000. Cost/Day: $0.28 - $2.00. View Cached Page >> Ads: Advertisers: 8 ... Search Results: Results: 935,000. 1. elcomercio.com.pe. Busco ...
http://www.spyfu.com/Term.aspx?t=235769
Griffon Operating Results for the Fourth Quarter
... Corporation Announces Operating Results for the Fourth Quarter ... the quarter was $10,935,000 compared to $12,379,000 for the fourth quarter of last year. ...
http://www.griffoncorp.com/relxi598.html
AVI BioPharma Announces 2006 Fourth Quarter and Full Year Financial Results
AVI BioPharma is focused on the discovery and development of RNA-based drugs utilizing proprietary derivatives of ... expenses of $935,000 recognized in ...
http://www.avibio.com/pr/pr334.php
|
